Official Publications Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:38 2024-12-04 am EST			5-day change	1st Jan Change
90.10 ^CHF	-3.14%		-2.86%	+6.16%

Dec. 04	Novartis cannot block generic of best-selling heart drug, US appeals court says	RE
Dec. 04	HSBC Downgrades Novartis to Reduce, Price Target is $95	MT

Slide show Q3	Oct. 28	CO
3rd quarter results	Oct. 28	CO
3rd quarter results	Oct. 28	CO
3rd quarter report	Oct. 28	CO
Slide show half-year results	Jul. 17	CO
1st-half-year results	Jul. 17	CO
1st-half-year results	Jul. 17	CO
1st-half-year results	Jul. 17	CO
Half-year report	Jul. 17	CO
Slide show Q1	Apr. 22	CO
1st quarter results	Apr. 22	CO
1st quarter results	Apr. 22	CO
1st quarter results	Apr. 22	CO
1st quarter report	Apr. 22	CO
Shareholders meeting voting results	Mar. 04	CO
Minutes of the general assembly	Mar. 04	CO
Minutes of the general assembly	Mar. 04	CO
Minutes of the general assembly	Mar. 04	CO
Changes in management and corporate officers	Feb. 15	CO
Slide show results	Jan. 30	CO
Annual results	Jan. 30	CO
Annual results	Jan. 30	CO
Annual results	Jan. 30	CO
SEC Filing 20 F	Jan. 30	CO
Integrated report	Jan. 30	CO

NOVARTIS : Q3 beat and a guidance upgrade; today’s dip is a buying opportunity

October 29, 2024 at 02:16 pm EDT

Vas Narasimhan, CEO of Novartis: 40% margin by 2027

Novartis AG : Sandoz takes its first steps on the stock exchange